Are Bank of Queensland shares worth buying in November?

Should you buy Bank of Queensland shares this month?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Bank of Queensland Ltd (ASX: BOQ) shares are edging higher on Tuesday.

At the time of writing, the regional bank's shares are up 0.3% to $7.24.

Though, that doesn't do much for their year to date performance. They remain down 13% since the start of the year.

A woman with black afro hair and wearing a white t-shirt shrugs and purses her lips

Image source: Getty Images

Are Bank of Queensland shares in the buy zone?

Opinion remains divided on where Bank of Queensland shares are heading from here.

For example, Macquarie currently has a neutral rating and $7.50 price target on the bank's shares. This offers extremely modest upside from current levels.

Goldman Sachs is also sitting on the fence and has a neutral rating and $8.51 price target. While this implies decent upside for its shares, the broker believes there are better options in the sector for investors to buy. It explained:

Despite valuation support, we believe its NIM leverage will ultimately underperform peers and its expenses will remain under pressure given the current inflationary environment and headwinds from running legacy systems along with building its new digital bank, which are expected to offset ME Bank synergies and restructuring benefits.

Who is bullish?

The team at Citi is bullish and sees plenty of upside for Bank of Queensland's shares.

Its analysts currently have a buy rating and $8.75 price target on the company's shares. This implies potential upside of almost 21% for investors over the next 12 months. Citi also expects an ~8% dividend yield in FY 2023.

The broker believes the market has been underestimating Bank of Queensland's leverage to rising rates. It highlights that management's commentary following its results release last month shows the opposite. Citi commented:

In our view, consensus has been underestimating the extent of rates leverage across the sector, which coupled with a view that BOQ has less rates leverage than peers. This had left very modest NIM expectations for FY23. Today, management dispelled these modest expectations, with bullish commentary on the exit NIM.

Time will tell which brokers make the right call on Bank of Queensland shares.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Westpac and CBA shares

A leading expert forecasts growing headwinds for Westpac and CBA shares.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Broker Notes

Expert names 2 ASX tech shares to buy today

A top analyst says these two ASX tech stocks are well-positioned to outperform.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

4 ASX All Ords shares with 40% to 90% upside post-results: experts

These shares have major upside potential, according to the experts.

Read more »

Woman looking at a laptop and thinking.
Broker Notes

4 ASX shares scoring upgrades in the final week of earnings season

Brokers have increased their ratings on Sigma Healthcare, Adairs, Netwealth, and other shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Buy, hold, sell: Netwealth, Sigma Healthcare, and Wesfarmers shares

The team at Morgans has given its verdict on these shares.

Read more »

Smiling kid flexing his muscles.
Broker Notes

3 ASX 200 shares to buy post-results: broker

Morgans has reviewed these companies' FY26 reports and given them a buy rating.

Read more »

Small kid giving a thumbs up.
Broker Notes

9 ASX 200 shares with strengthened buy ratings this week

Brokers are positive on Paladin Energy, Coles, WiseTech, Centuria Capital, and other shares.

Read more »

A couple in a supermarket laugh as they discuss which fruits and vegetables to buy
Broker Notes

Buy, hold, sell: Ramsay Health Care, PLS Group, Woolworths shares

Morgans has updated its ratings and 12-month price targets on these 3 ASX 200 shares.

Read more »